 Histocompatibility Testing
"Histocompatibility Testing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)
| Descriptor ID |
D006650
|
| MeSH Number(s) |
E01.370.225.812.385 E05.200.812.385 E05.478.594.385
|
| Concept/Terms |
Histocompatibility Testing- Histocompatibility Testing
- Histocompatibility Testings
- Testing, Histocompatibility
- Testings, Histocompatibility
- Crossmatching, Tissue
- Crossmatchings, Tissue
- Tissue Crossmatching
- Tissue Crossmatchings
- Tissue Typing
- Tissue Typings
- Typing, Tissue
- Typings, Tissue
HLA Typing- HLA Typing
- HLA Typings
- Typing, HLA
- Typings, HLA
|
Below are MeSH descriptors whose meaning is more general than "Histocompatibility Testing".
Below are MeSH descriptors whose meaning is more specific than "Histocompatibility Testing".
This graph shows the total number of publications written about "Histocompatibility Testing" by people in this website by year, and whether "Histocompatibility Testing" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 0 | 1 | 1 | | 1982 | 0 | 1 | 1 | | 1984 | 1 | 0 | 1 | | 1986 | 1 | 0 | 1 | | 1987 | 2 | 2 | 4 | | 1990 | 1 | 0 | 1 | | 1991 | 1 | 0 | 1 | | 1992 | 0 | 2 | 2 | | 1993 | 1 | 2 | 3 | | 1994 | 0 | 1 | 1 | | 1995 | 1 | 2 | 3 | | 1996 | 1 | 3 | 4 | | 1997 | 2 | 3 | 5 | | 1998 | 1 | 3 | 4 | | 1999 | 3 | 5 | 8 | | 2000 | 3 | 4 | 7 | | 2001 | 1 | 1 | 2 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2004 | 1 | 2 | 3 | | 2005 | 0 | 3 | 3 | | 2006 | 0 | 2 | 2 | | 2007 | 0 | 1 | 1 | | 2008 | 1 | 8 | 9 | | 2009 | 0 | 4 | 4 | | 2010 | 1 | 5 | 6 | | 2011 | 1 | 3 | 4 | | 2012 | 0 | 1 | 1 | | 2013 | 2 | 2 | 4 | | 2014 | 2 | 1 | 3 | | 2015 | 2 | 1 | 3 | | 2016 | 0 | 4 | 4 | | 2017 | 1 | 2 | 3 | | 2018 | 0 | 1 | 1 | | 2019 | 0 | 2 | 2 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Histocompatibility Testing" by people in Profiles.
-
Geffard E, Limou S, Walencik A, Daya M, Watson H, Torgerson D, Barnes KC. Easy-HLA: a validated web application suite to reveal the full details of HLA typing. Bioinformatics. 2020 04 01; 36(7):2157-2164.
-
Van Besien K, Bachier-Rodriguez L, Satlin M, Brown MA, Gergis U, Guarneri D, Hsu J, Phillips AA, Mayer SA, Singh AD, Soave R, Rossi A, Small CB, Walsh TJ, Rennert H, Shore TB. Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leuk Lymphoma. 2019 07; 60(7):1693-1696.
-
Kone A, Diarra B, Cohen K, Diabate S, Kone B, Diakite MT, Diarra H, Sanogo M, Togo ACG, Sarro YDS, Baya B, Coulibaly N, Kodio O, Achenbach CJ, Murphy RL, Holl JL, Siddiqui S, Doumbia S, Bishai WR, Diallo S, Maiga M. Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali. HLA. 2019 01; 93(1):24-31.
-
Chong AS, Ansari MJ. Heterogeneity of memory B cells. Am J Transplant. 2018 04; 18(4):779-784.
-
Tsai SB, Rhodes J, Liu H, Shore T, Bishop M, Cushing MM, Gergis U, Godley L, Kline J, Larson RA, Mayer S, Odenike O, Stock W, Wickrema A, van Besien K, Artz AS. Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults. Biol Blood Marrow Transplant. 2018 05; 24(5):997-1004.
-
Brown NK, Meade JR, Wang J, Marino SR. Reanalysis of the role of pronase treatment of B cells in the flow cytometric crossmatch assay: Fc receptor is not the primary target. Hum Immunol. 2017 Nov; 78(11-12):704-709.
-
Wang J, Meade JR, Brown NK, Weidner JG, Marino SR. EDTA is superior to DTT treatment for overcoming the prozone effect in HLA antibody testing. HLA. 2017 02; 89(2):82-89.
-
Kiyotani K, Mai TH, Nakamura Y. Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors. J Hum Genet. 2017 Mar; 62(3):397-405.
-
van Besien K, Koshy N, Gergis U, Mayer S, Cushing M, Rennert H, Reich-Slotky R, Mark T, Pearse R, Rossi A, Phillips A, Vasovic L, Ferrante R, Hsu YM, Shore T. Haplo-cord transplant: HLA-matching determines graft dominance. Leuk Lymphoma. 2017 06; 58(6):1512-1514.
-
van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman S, Artz A. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival. Haematologica. 2016 05; 101(5):634-43.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|